Professor David Loughton spent 40 years in NHS management, 36 of them as a chief executive. When he stepped down from the Royal Wolverhampton and Walsall Healthcare NHS Trusts in spring 2024, the language from those around him was final. The chair, Sir David Nicholson, wished him "a well-earned retirement" and pledged to build on his "fantastic legacy." Six months later, a permanent chief executive was announced. The chapter, it seemed, was closed.

It has since reopened.

Now 70, Loughton has agreed to return in an interim capacity, taking the helm of a hospital group that has been unable to stabilise its finances or performance. The appointment follows a period in which senior leadership changes failed to arrest deteriorating waiting times, a strained emergency department, and a financial deficit drawing scrutiny from NHS England. A permanent recruitment process is expected to follow, though no timeline has been set.

The trust's immediate problems are not abstract. Emergency waiting times have exceeded national targets consistently across two consecutive quarters. The financial position has worsened despite assurances to NHS England that a recovery plan was in place. Staff vacancy rates in key clinical areas remain above the national average. The board's difficulty securing a permanent chief executive capable of commanding confidence from both clinical staff and NHS England created the conditions for an emergency interim appointment and that search landed on a man who had already left the profession.

Loughton began his chief executive career at University Hospitals Coventry and Warwickshire in 1986. He joined the Royal Wolverhampton NHS Trust in 2004, leading the organisation from one of the most financially challenged positions in the NHS to stability, while building a reputation for patient safety improvement. In 2021, he took on the neighbouring Walsall Healthcare NHS Trust, which had previously been placed in special measures in 2016 and still rated "requires improvement" by the Care Quality Commission. The chair at the time said his "expertise and leadership brings a timely and high-quality response to enable Walsall's improvement journey." The phrasing could be applied to his current appointment without adjustment.

That is partly what makes the decision to call him back comprehensible. The NHS has a well-documented problem with succession in senior trust leadership. The pool of credible candidates with experience managing multi-site hospital groups under financial pressure has thinned considerably. When a board faces a genuine operational crisis and a weak recruitment field, a known quantity becomes disproportionately attractive, regardless of age or stated plans.  

The limitations of the interim model deserve scrutiny. An interim appointment is a stabilisation exercise, it can stop the bleeding, but it cannot redesign the operating theatre. Loughton's immediate priorities are likely to focus on emergency performance, the financial deficit, and staff retention in departments with the highest vacancy rates. These are achievable within a short-term mandate. What they do not address is the structural question of why this group reached crisis without triggering the internal succession mechanisms that should have prevented one retired executive from being the answer.

There is also the question of what returning costs personally. NHS trust leadership at group level is not a low-intensity role. The pressures accompanying a failing organisation, political exposure, regulatory correspondence, collapsed staff morale are not conditions in which a newly retired professional might expect to find themselves. That Loughton accepted speaks to institutional loyalty, a genuine belief he can make a difference, and perhaps an unwillingness to watch from a distance.

The board will argue it had few alternatives, and it may be right. But the fact that a 70-year-old who declared his retirement two years ago is now running a struggling NHS hospital group is not merely a story about one man's career. It is an indictment of how poorly the wider health system has managed the pipeline of leaders capable of taking on its most difficult institutions. Loughton's return solves an immediate problem. It does nothing to address the structural one.

‍